AU4337099A - Zmpb, a new determinant of virulence for (streptococcus pneumoniae), vaccine derived therefrom and uses thereof - Google Patents

Zmpb, a new determinant of virulence for (streptococcus pneumoniae), vaccine derived therefrom and uses thereof

Info

Publication number
AU4337099A
AU4337099A AU43370/99A AU4337099A AU4337099A AU 4337099 A AU4337099 A AU 4337099A AU 43370/99 A AU43370/99 A AU 43370/99A AU 4337099 A AU4337099 A AU 4337099A AU 4337099 A AU4337099 A AU 4337099A
Authority
AU
Australia
Prior art keywords
zmpb
virulence
derived therefrom
streptococcus pneumoniae
vaccine derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43370/99A
Inventor
Robert Masure
Rodger Novak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Jude Childrens Research Hospital
Original Assignee
St Jude Childrens Research Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Childrens Research Hospital filed Critical St Jude Childrens Research Hospital
Publication of AU4337099A publication Critical patent/AU4337099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
AU43370/99A 1998-06-11 1999-06-11 Zmpb, a new determinant of virulence for (streptococcus pneumoniae), vaccine derived therefrom and uses thereof Abandoned AU4337099A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9633698A 1998-06-11 1998-06-11
US09096336 1998-06-11
US09329834 1999-06-10
PCT/US1999/012939 WO1999064610A1 (en) 1998-06-11 1999-06-11 ZmpB, A NEW DETERMINANT OF VIRULENCE FOR STREPTOCOCCUS PNEUMONIAE, VACCINE DERIVED THEREFROM AND USES THEREOF

Publications (1)

Publication Number Publication Date
AU4337099A true AU4337099A (en) 1999-12-30

Family

ID=22256885

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43370/99A Abandoned AU4337099A (en) 1998-06-11 1999-06-11 Zmpb, a new determinant of virulence for (streptococcus pneumoniae), vaccine derived therefrom and uses thereof

Country Status (2)

Country Link
AU (1) AU4337099A (en)
WO (1) WO1999064610A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3664102A (en) * 2000-12-01 2002-06-11 Battelle Memorial Institute Method for stabilizing biomolecules in liquid formulations
AU2002236641B2 (en) * 2000-12-01 2006-08-03 Battelle Memorial Institute Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
FR2872289B1 (en) * 2004-06-29 2006-09-22 Abag Sa USE OF THE G5 PROTEIN IN IN VITRO DIAGNOSIS OF LEGIONELLA PNEUMOPHILA INFECTION
DE602005016417D1 (en) * 2004-06-29 2009-10-15 Ingen Biosciences NEW POLYPEPTIDES FOR IN VINTRO INSULATION AND PREVENTION OF INFECTIONS WITH LEGIONELLA PNEUMOPHILA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941335A2 (en) * 1996-10-31 1999-09-15 Human Genome Sciences Streptococcus pneumoniae polynucleotides and sequences

Also Published As

Publication number Publication date
WO1999064610A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
HK1043728B (en) Vaccine against streptococcus pneumoniae
AU2002351623A1 (en) Streptococcus antigens
IL194230A0 (en) Novel streptococcus antigens
AU2001262723A1 (en) 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
AU3764899A (en) High molecular weight polyols, process for preparation and use thereof
AU1929897A (en) Novel erythromycin derivatives, method for preparing same, and use thereof as drugs
AU2001269198A1 (en) Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
AU2002365394A1 (en) Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols, 3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols
PL348098A1 (en) Novel erythromycin derivatives, preparation method and use as medicines
AU3454399A (en) Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
HUP0201905A3 (en) Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
AU3187797A (en) Subunit vaccine for (streptococcus equi)
AUPR209000A0 (en) Regulation of bacterial virulence
AU6732598A (en) A biocompatible composition, methods for its preparation and uses thereof
AU4337099A (en) Zmpb, a new determinant of virulence for (streptococcus pneumoniae), vaccine derived therefrom and uses thereof
AU2001256223A1 (en) Phosphorous-aluminium-mixed oxide catalyst, process for its preparation and use thereof
CA2251297A1 (en) Oral preparations comprising s-(3-hydroxypropyl)-l-cysteine
AU2001234616A1 (en) Vaccine composition, process and methods
AU2001265384A1 (en) 52906, 33408, and 12189, potassium channel family members and uses thereof
AU2001266728A1 (en) 56201, a novel human sodium ion channel family member and uses thereof
AU2001288606A1 (en) 8797, a human galactosyltransferase and uses thereof
AU1540501A (en) Streptococcus pneumoniae antigens
AU3593200A (en) (mycobacterium tuberculosis), immunization
AU2361495A (en) A novel vzv gene, mutant vzv and immunogenic compositions
AU7913300A (en) Novel immobilizable amylosucrase, the use thereof and method for producing poly(1,4-alpha-glucan)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase